McGuyer Frank B

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
McGuyer Frank B
CIK #0001626889
EDGAR Form CIK 2011 - 2026
3 [0001626889]
4 [0001626889]
Form 3/4/5 Subject 2011 - 2026
Bellicum Pharmaceuticals Inc
McGuyer Frank B
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
2018-06-14 Grant 10,000 $0.00
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
2017-06-14 Grant 10,000 $0.00
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
2016-06-15 Grant 10,000 $0.00
Bellicum Pharmaceuticals Inc BLCM
Stock Option (right to buy) · derivative
2015-06-17 Grant 10,000 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2014-12-23 Conversion 298,434
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2014-12-23 Conversion 1,227,132
Bellicum Pharmaceuticals Inc BLCM
Series C Convertible Preferred Stock · derivative
2014-12-23 Conversion 333,536 $0.00
Bellicum Pharmaceuticals Inc BLCM
Series A Convertible Preferred Stock · derivative
2014-12-23 Conversion 507,339 $0.00
Bellicum Pharmaceuticals Inc BLCM
Series C Convertible Preferred Stock · derivative
2014-12-23 Conversion 513,133 $0.00
Bellicum Pharmaceuticals Inc BLCM
Series B Convertible Preferred Stock · derivative
2014-12-23 Conversion 2,086,125 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2014-12-23 Other 44,735 $0.00
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2014-12-23 Conversion 196,197
Bellicum Pharmaceuticals Inc BLCM
Common Stock
2014-12-23 Conversion 301,842
Bellicum Pharmaceuticals Inc BLCM
Warrant to Purchase Series C Preferred Stock (right to buy) · derivative
2014-12-17 Option exercise 333,536 $0.00
Bellicum Pharmaceuticals Inc BLCM
Series C Convertible Preferred Stock · derivative
2014-12-17 Option exercise 333,536
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com